- Planova FG1 features a hydrophilic modified polyethersulfone membrane for high permeability and virus retention.
- FG1 maintains virus clearance after a 120-minute pause and integrates with steam-in-place protocols.
- In May 2024, Asahi Kasei opened a new Planova filter assembly plant in Nobeoka City, Japan.
- The 26th Planova Workshop will be held on November 13–14, 2025, in Monaco.
Innovation in Biomanufacturing
Asahi Kasei's Planova FG1 filter has been recognized with the Biomanufacturing Innovation of the Year award at the 2025 BioTech Breakthrough Awards. The filter is designed to enhance high-throughput biologics production with a newly engineered hydrophilic modified polyethersulfone membrane, offering high permeability and robust virus retention.
Advancements in Virus Filtration
Building on the legacy of the Planova series, the FG1 model continues to improve safety and efficiency in biopharmaceutical manufacturing. It maintains reliable virus clearance even after a 120-minute process pause and integrates seamlessly into existing systems with compatibility for steam-in-place and clean-in-place protocols.
Operational Flexibility and Sustainability
With a water flux of 1,220 liters per square meter per hour at 49.7 psi, the FG1 filter accelerates processing and reduces costs. These features enhance operational flexibility and support more sustainable production in response to the growing global demand for biologics.
Expansion and Collaboration
In May 2024, Asahi Kasei expanded its Planova business by opening a new assembly plant in Nobeoka City, Japan. Additionally, the company will host the 26th Planova Workshop on November 13–14, 2025, in Monaco, providing a platform for users to exchange insights and best practices in virus filtration.
